News
In a new study published in Nature titled, “Custom CRISPR-Cas9 PAM variants via scalable ... sequences while limiting off-target effects. Cas nucleases recognize genomic targets by reading ...
Using systematic screening of actin tail formation in two bacterial strains and employing a panel of CRISPR-CAS ko cell lines ... the authors performed an siRNA screen of interferon-stimulated genes ...
Search for other works by this author on: ...
The University of Bayreuth's Biomaterials research group has, for the first time, successfully applied the CRISPR-Cas9 ...
Researchers at Novartis BioMedical Research in the US and Switzerland have identified a molecular target that may provide a ...
In the study, "Targeting the SHOC2–RAS interaction in RAS-mutant cancers," published in Nature, researchers conducted a genome-wide CRISPR screen to identify genetic dependencies associated with ...
The University of California and the University of Vienna on Monday convinced a U.S. appeals court to revive their bid for ...
CRISPR Therapeutics has begun realizing sales on Casgevy, its first therapy and a joint venture with Vertex Pharmaceuticals. The company has plenty of cash to fund research and development for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results